Search Results

SNS-032 (BMS-387032) 25mg  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)

SNS-032 (BMS-387032) 5mg  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)

SNS-032 (BMS-387032) Evaluation Sample  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)

Etomidate 25mg  | 98%

APEXBIO TECHNOLOGY LLC

General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor

More Information Supplier Page

×

Etomidate

Etomidate 100mg  | 98%

APEXBIO TECHNOLOGY LLC

General anesthetic with GABA modulatory and GABA-mimetic actions Neuroscience|GABA Receptor

More Information Supplier Page

×

Etomidate

Etoposide 10mM (in 1mL DMSO)  | 99.81%

APEXBIO TECHNOLOGY LLC

Topo II inhibitor DNA Damage/DNA Repair|Topoisomerase

More Information Supplier Page

×

Etoposide

Etoposide 100mg  | 99.81%

APEXBIO TECHNOLOGY LLC

Topo II inhibitor DNA Damage/DNA Repair|Topoisomerase

More Information Supplier Page

×

Etoposide

SNS-032 (BMS-387032) 10mM (in 1mL DMSO)  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)

NSC 23766 5mg  | 98.57%

APEXBIO TECHNOLOGY LLC

Selective inhibitor of Rac1-GEF interaction. Cell Cycle/Checkpoint|Rho

More Information Supplier Page

×

NSC 23766

NSC 23766 25mg  | 98.57%

APEXBIO TECHNOLOGY LLC

Selective inhibitor of Rac1-GEF interaction. Cell Cycle/Checkpoint|Rho

More Information Supplier Page

×

NSC 23766